Bostrycin inhibits proliferation of human lung carcinoma A549 cells via downregulation of the PI3K/Akt pathwayWei‐Sheng Chen(Tufts University), Zhigang She(Sun Yat-sen University)Journal of Experimental & Clinical Cancer ResearchFebruary 8, 201110.1186/1756-9966-30-17Cited by 35SaveCiteExport RISWatch citationsRelated PapersPathological lymphangiogenesis is modulated by galectin-8-dependent crosstalk between podoplanin and integrin-associated VEGFR-3|Nature Communications|2016|102